Efficacy and Safety of Tirabrutinib and Idelalisib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia.
Nadine Kutsch,Christian Pallasch,Thomas Decker,Holger Hebart,Kai Uwe Chow,Ullrich Graeven,Jens Kisro, Alexander Kroeber,Eugen Tausch,Kirsten Fischer,Anna-Maria Fink,Clemens-Martin Wendtner,Matthias Ritgen,Stephan Stilgenbauer,Danjie Zhang,Biao Li,Juliane M Jürgensmeier,Nishanthan Rajakumaraswamy,Pankaj Bhargava,Michael Hallek,Barbara Eichhorst HEMASPHERE（2022）
AI 理解论文
溯源树
样例
